Virtual Sexual Health and Rehabilitation eClinic for Prostate Cancer Patients
Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners
This study is testing a virtual clinic that helps prostate cancer patients and their partners manage sexual health issues after treatment to see if it improves their sexual function and relationship satisfaction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 575 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 10 sites (Vancouver, British Columbia and 9 other locations) |
| Trial ID | NCT06877598 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the effectiveness of SHAReClinic, a national virtual eClinic aimed at supporting prostate cancer patients and their partners in managing sexual health issues post-treatment. The study assesses the impact of guided education modules and sexual health counseling on improving sexual function, satisfaction, and relational intimacy. By expanding access to sexual health care, SHAReClinic seeks to address the significant unmet needs of prostate cancer survivors and their partners across Canada. The findings will contribute to best practices in survivorship care and help establish a national standard for oncology sexual health.
Who should consider this trial
Good fit: Ideal candidates include men scheduled for first-line treatment for localized prostate cancer or those currently undergoing treatment or who have been treated within the last six months.
Not a fit: Patients receiving androgen deprivation therapy as primary treatment or those with contraindications to sexual activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the sexual health and quality of life for prostate cancer patients and their partners.
How similar studies have performed: While similar approaches have been explored, this specific implementation of a virtual sexual health clinic for prostate cancer patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who are scheduled for first-line treatment for localized prostate cancer, either through radical prostatectomy (open or robotic) or radiation treatment (brachytherapy, external beam) Alone, or with adjuvant Androgen Deprivation Therapy (ADT) OR * Patients currently undergoing active treatment for prostate cancer OR * Patients who have undergone cancer treatment in the past 6 months * Patients who are hormone and/or chemotherapy-naïve * Patients who have access to a computer or smartphone with internet access * Patients who are 18 years of age or older Exclusion Criteria: * Patients on ADT alone as primary treatment, and/or patients on chemotherapy * Patients who lack English proficiency * Patients on nitrate therapy or have other contra-indications to phosphodiesterase type 5 inhibitors (PDE5i's) * Patients with medical conditions that would preclude safe sexual activity * Patients who have had previous treatment for PCa
Where this trial is running
Vancouver, British Columbia and 9 other locations
- Vancouver Coastal Health Authority — Vancouver, British Columbia, Canada (Recruiting)
- Men's Health Clinic Manitoba — Winnipeg, Manitoba, Canada (Recruiting)
- Royal Victoria Regional Health Centre — Barrie, Ontario, Canada (Recruiting)
- Dianne & Irving Kipnes Urology Centre — Edmonton, Ontario, Canada (Not_yet_recruiting)
- Kingston Health Sciences Centre — Kingston, Ontario, Canada (Recruiting)
- St. Joseph's Health Care London — London, Ontario, Canada (Not_yet_recruiting)
- Trillium Health Partners — Mississauga, Ontario, Canada (Not_yet_recruiting)
- Grass Family Men's Health Center — Ottawa, Ontario, Canada (Recruiting)
- University Health Network — Toronto, Ontario, Canada (Recruiting)
- St. Paul's Hospital — Saskatoon, Saskatchewan, Canada (Not_yet_recruiting)
Study contacts
- Principal investigator: Andrew Matthew, PhD. C.Psych — Princess Margaret Cancer Centre
- Study coordinator: Steven Guirguis, MA
- Email: steven.guirguis@uhn.ca
- Phone: 416-946-4501
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.